Laser ablation for small hepatocellular carcinoma

Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo, Claudio Maurizio Pacella, Giampiero Francica, Giovanni Giuseppe Di Costanzo

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and is increasingly detected at small size (<5 cm) owing to surveillance programmes in high-risk patients. For these cases, curative therapies such as resection, liver transplantation, or percutaneous ablation have been proposed. When surgical options are precluded, image-guided tumor ablation is recommended as the most appropriate therapeutic choice in terms of tumor local control, safety, and improvement in survival. Laser ablation (LA) represents one of currently available loco-ablative techniques: light is delivered via flexible quartz fibers of diameter from 300 to 600 μm inserted into tumor lesion through either fine needles (21g Chiba needles) or large-bore catheters. The thermal destruction of tissue is achieved through conversion of absorbed light (usually infrared) into heat. A range of different imaging modalities have been used to guide percutaneous laser ablation, but ultrasound and magnetic resonance imaging are most widely employed, according to local experience and resource availability. Available clinical data suggest that LA is highly effective in terms of tumoricidal capability with an excellent safety profile; the best results in terms of long-term survival are obtained in early HCC so that LA can be proposed not only in unresectable cases but, not differently from radiofrequency ablation, also as the first-line treatment.

References

    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca: A Cancer Journal for Clinicians. 2005;55(2):74–108.
    1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. The New England Journal of Medicine. 1999;340(10):745–750.
    1. Olsen AH, Parkin DM, Sasieni P. Cancer mortality in the United Kingdom: projections to the year 2025. British Journal of Cancer. 2008;99(9):1549–1554.
    1. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138(2):513–521.
    1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. The Lancet. 1981;2(8256):1129–1132.
    1. Sherman M. Surveillance for hepatocellular carcinoma and early diagnosis. Clinics in Liver Disease. 2007;11(4):817–837.
    1. Sun CA, Wu DM, Lin CC, et al. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. American Journal of Epidemiology. 2003;157(8):674–682.
    1. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut. 2000;47(1):131–136.
    1. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. Journal of Hepatology. 2001;35(3):421–430.
    1. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48(2):251–259.
    1. Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126(4):1005–1014.
    1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236.
    1. Lang BHH, Poon RTP, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Archives of Surgery. 2003;138(11):1207–1213.
    1. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91(8):1479–1486.
    1. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World Journal of Gastroenterology. 2002;8(2):237–242.
    1. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–1440.
    1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England Journal of Medicine. 1996;334(11):693–699.
    1. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. The Lancet Oncology. 2009;10(1):35–43.
    1. Llovet JM, Mas X, Aponte JJ, et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002;50(1):123–128.
    1. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. Journal of Hepatology. 2008;48(1):S20–S37.
    1. Tranberg KG. Percutaneous ablation of liver tumours. Best Practice and Research: Clinical Gastroenterology. 2004;18(1):125–145.
    1. Brown DB, Geschwind JFH, Soulen MC, Millward SF, Sacks D. Society of Interventional radiology position statement on chemoembolization of hepatic malignancies. Journal of Vascular and Interventional Radiology. 2009;20(7):S317–S323.
    1. Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology. 2008;66(3):200–207.
    1. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–739.
    1. Ahmed M, Brace CL, Lee Jr. FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
    1. Bown SG. Phototherapy of tumors. World Journal of Surgery. 1983;7(6):700–709.
    1. Masters A, Bown SG. Interstitial laser hyperthermia in tumour therapy. Annales Chirurgiae et Gynaecologiae. 1990;79(4):244–251.
    1. Dachman AH, McGehee JA, Beam TE, Burris JA, Powell DA. US-guided percutaneous laser ablation of liver tissue in a chronic pig model. Radiology. 1990;176(1):129–133.
    1. Thomsen S. Pathologic analysis of photothermal and photomechanical effects of laser-tissue interactions. Photochemistry and Photobiology. 1991;53(6):825–835.
    1. Jacques SL. Laser-tissue interactions: photochemical, photothermal, and photomechanical. Surgical Clinics of North America. 1992;72(3):531–558.
    1. Nolsoe CP, Torp-Pedersen S, Burcharth F, et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology. 1993;187(2):333–337.
    1. Amin Z, Harries SA, Lees WR, Bown SG. Interstitial tumour photocoagulation. Endoscopic Surgery and Allied Technologies. 1993;1(4):224–229.
    1. Germer CT, Roggan A, Ritz JP, et al. Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range. Lasers in Surgery and Medicine. 1998;23(4):194–203.
    1. Heisterkamp J, van Hillegersberg R, IJzermans JNM. Interstitial laser coagulation for hepatic tumours. British Journal of Surgery. 1999;86(3):293–304.
    1. Wyman DR, Whelan WM, Wilson BC. Interstitial laser photocoagulation: Nd:YAG 1064 nm optical fiber source compared to point heat source. Lasers in Surgery and Medicine. 1992;12(6):659–664.
    1. Ahrar K, Gowda A, Javadi S, et al. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. Journal of Vascular and Interventional Radiology. 2010;21(4):555–561.
    1. Wheatley DN, Kerr C, Gregory DW. Heat-induced damage to HeLa-S3 cells: correlation of viability, permeability, osmosensitivity, phase-contrast light-, scanning electron- and transmission electron-microscopical findings. International Journal of Hyperthermia. 1989;5(2):145–162.
    1. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surgical Oncology. 1998;7(1-2):83–90.
    1. Möller PH, Ivarsson K, Stenram U, Radnell M, Tranberg KG. Interstitial laser thermotherapy of adenocarcinoma transplanted into rat liver. European Journal of Surgery. 1997;163(11):861–870.
    1. Ritz JP, Roggan A, Germer CT, Isbert C, Mller G, Buhr HJ. Continuous changes in the optical properties of liver tissue during laser-induced interstitial thermotherapy. Lasers in Surgery and Medicine. 2001;28(4):307–312.
    1. Steger AC, Lees WR, Shorvon P, Walmsley K, Bown SG. Multiple-fibre low-power interstitial laser hyperthermia: studies in the normal liver. British Journal of Surgery. 1992;79(2):139–145.
    1. Ivarsson K, Olsrud J, Sturesson C, Möller PH, Persson BR, Tranberg KG. Feedback interstitial diode laser (805 nm) thermotherapy system: ex vivo evaluation and mathematical modeling with one and four-fibers. Lasers in Surgery and Medicine. 1998;22(2):86–96.
    1. Vogl TJ, Straub R, Eichler K, Söllner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy—local tumor control rate and survival data. Radiology. 2004;230(2):450–458.
    1. Veenendaal LM, de Jager A, Stapper G, Borel Rinkes IHM, van Hillegersberg R. Multiple fiber laser-induced thermotherapy for ablation of large intrahepatic tumors. Photomedicine and Laser Surgery. 2006;24(1):3–9.
    1. Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions) Radiology. 2002;225(2):367–377.
    1. Whelan WM, Wyman DR, Wilson BC. Investigations of large vessel cooling during interstitial laser heating. Medical Physics. 1995;22(1):105–115.
    1. Heisterkamp J, van Hillegersberg R, Mulder PGH, Sinofsky EL, Ijzermans JNM. Importance of eliminating portal flow to produce large intrahepatic lesions with interstitial laser coagulation. British Journal of Surgery. 1997;84(9):1245–1248.
    1. Möller PH, Hannesson PH, Ivarsson K, Olsrud J, Stenram U, Tranberg KG. Interstitial laser thermotherapy in pig liver: effect of inflow occlusion on extent of necrosis and ultrasound image. Hepato-Gastroenterology. 1997;44(17):1302–1311.
    1. Germer CT, Isbert C, Albrecht D, et al. Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model. Annals of Surgery. 1999;230(1):55–62.
    1. Wacker FK, Reither K, Ritz JP, Roggan A, Germer CT, Wolf KJ. MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. Journal of Magnetic Resonance Imaging. 2001;13(1):31–36.
    1. Muralidharan V, Malcontenti-Wilson C, Christophi C. Effect of blood flow occlusion on laser hyperthermia for liver metastases. Journal of Surgical Research. 2002;103(2):165–174.
    1. Möller PH, Lindberg L, Henriksson PH, Persson BRR, Tranberg KG. Temperature control and light penetration in a feedback interstitial laser thermotherapy system. International Journal of Hyperthermia. 1996;12(1):49–63.
    1. Kettenbach J, Silverman SG, Hata N, et al. Monitoring and visualization techniques for MR-guided laser ablations in an open MR system. Journal of Magnetic Resonance Imaging. 1998;8(4):933–943.
    1. Olsrud J, Wirestam R, Persson BRR, Tranberg KG. Simplified treatment planning for interstitial laser thermotherapy by disregarding light transport: a numerical study. Lasers in Surgery and Medicine. 1999;25(4):304–314.
    1. Pacella CM, Bizzarri G, Francica G, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. Journal of Vascular and Interventional Radiology. 2005;16(11):1447–1457.
    1. Huang GT, Wang TH, Sheu JC, et al. Low-power laserthermia for the treatment of small hepatocellular carcinoma. European Journal of Cancer. 1991;27(12):1622–1627.
    1. Muralidharan V, Malcontenti-Wilson C, Christophi C. Interstitial laser hyperthermia for colorectal liver metastases: the effect of thermal sensitization and the use of a cylindrical diffuser tip on tumor necrosis. Journal of Clinical Laser Medicine and Surgery. 2002;20(4):189–196.
    1. Vogl TJ, Straub R, Zangos S, Mack MG, Eichler K. MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. International Journal of Hyperthermia. 2004;20(7):713–724.
    1. Tranberg KG, Möller PH, Hannesson P, Stenram U. Interstitial laser treatment of malignant tumours: initial experience. European Journal of Surgical Oncology. 1996;22(1):47–54.
    1. Malone DE, Wyman DR, DeNardi FG, McGrath FP, de Gara CJ, Wilson BC. Hepatic interstitial laser photocoagulation: an investigation of the relationship between acute thermal lesions and their sonographic images. Investigative Radiology. 1994;29(10):915–921.
    1. Harries SA, Amin Z, Smith MEF, et al. Interstitial laser photocoagulation as a treatment for breast cancer. British Journal of Surgery. 1994;81(11):1617–1619.
    1. Joarder R, de Jode M, Lamb GA, Gedroyc WMW. The value of MnDPDP enhancement during MR guided laser interstitial thermoablation of liver tumors. Journal of Magnetic Resonance Imaging. 2001;13(1):37–41.
    1. Vogl TJ, Eichler K, Straub R, et al. Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s)—side effects, complications and results. European Journal of Ultrasound. 2001;13(2):117–127.
    1. Dick EA, Joarder R, de Jode M, et al. MR-guided laser thermal ablation of primary and secondary liver tumours. Clinical Radiology. 2003;58(2):112–120.
    1. Puls R, Langner S, Rosenberg C, et al. Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival. Journal of Vascular and Interventional Radiology. 2009;20(2):225–234.
    1. Puls R, Stroszczynski C, Rosenberg C, et al. Three-dimensional gradient-echo imaging for percutaneous MR-guided laser therapy of liver metastasis. Journal of Magnetic Resonance Imaging. 2007;25(6):1174–1178.
    1. Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221(3):712–720.
    1. Matsumoto R, Mulkern RV, Hushek SG, Jolesz FA. Tissue temperature monitoring for thermal interventional therapy: comparison of T1-weighted MR sequences. Journal of Magnetic Resonance Imaging. 1994;4(1):65–70.
    1. MacFall JM, Prescott DM, Fullar E, Samulski TV. Temperature dependence of canine brain tissue diffusion coefficient measured in vivo with magnetic resonance echo-planar imaging. International Journal of Hyperthermia. 1995;11(1):73–86.
    1. Peters RD, Hinks RS, Henkelman RM. Heat-source orientation and geometry dependence in proton-resonance frequency shift magnetic resonance thermometry. Magnetic Resonance in Medicine. 1999;41(5):909–918.
    1. Dick EA, Wragg P, Joarder R, et al. Feasibility of abdomino-pelvic T1-weighted real-time thermal mapping of laser ablation. Journal of Magnetic Resonance Imaging. 2003;17(2):197–205.
    1. Gedroyc WMW. Magnetic resonance guidance of thermal ablation. Topics in Magnetic Resonance Imaging. 2006;16(5):339–353.
    1. Roggan A, Mesecke-von Rheinbaben I, Knappe V, et al. Applicator development and irradiation planning in laser-induced thermotherapy (LITT) Biomedical Engineering. 1997;42:332–333.
    1. Eichler K, Mack MG, Straub R, et al. Oligonodular hepatocellular carcinoma (HCC): MR-guided laser-induced thermotherapy (LITT) Radiologe. 2001;41(10):915–922.
    1. Pompili M, Pacella CM, Francica G, et al. Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. European Journal of Radiology. 2010;74(3):e6–e11.
    1. Giorgio A, Tarantino L, de Stefano G, et al. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. European Journal of Ultrasound. 2000;11(3):181–188.
    1. Pacella CM, Bizzarri G, Francica G, et al. Analysis of factors predicting survival in patients with hepatocellular carcinoma treated with percutaneous laser ablation. Journal of Hepatology. 2006;44(5):902–909.
    1. Francica G, Iodice G, Delle Cave M, et al. Factors predicting complete necrosis rate after ultrasound-guided percutaneous laser thermoablation of small hepatocellular carcinoma tumors in cirrhotic patients: a multivariate analysis. Acta Radiologica. 2007;48(5):514–519.
    1. Pacella CM, Francica G, Di Lascio FML, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. Journal of Clinical Oncology. 2009;27(16):2615–2621.
    1. Pacella CM, Bizzarri G, Cecconi P, et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolizationi. Radiology. 2001;219(3):669–678.
    1. Ferrari FS, Stella A, Gambacorta D, et al. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results. Radiologia Medica. 2004;108(4):356–371.
    1. Arienti V, Pretolani S, Pacella CM, et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology. 2008;246(3):947–955.
    1. Ferrari FS, Megliola A, Scorzelli A, et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiologia Medica. 2007;112(3):377–393.
    1. Saverio Ferrari F, Stella A, Pasquinucci P, et al. Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results. European Journal of Gastroenterology and Hepatology. 2006;18(6):659–672.
    1. Gough-Palmer AL, Gedroyc WM. Laser ablation of hepatocellular carcinoma—a review. World Journal of Gastroenterology. 2008;14(47):7170–7174.
    1. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology. 2008;47(1):82–89.
    1. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40(6):1352–1360.
    1. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. Journal of Surgical Research. 2005;127(2):208–223.
    1. Abou-Alfa GK, Johnson P, Knox JJ, et al. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. Journal of the American Medical Association. 2010;304(19):2154–2160.
    1. Keating GM, Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs. 2009;69(2):223–240.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅